Buhlmann Laboratories AG – Trademark Portfolio
Entity Type: 03
Buhlmann Laboratories AG holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CAST. The owner is based in Schonenbuch.
Baselstrasse 55
Schonenbuch 4124 , CH
Showing of trademarks Trademarks
Trademark Classifications
Buhlmann Laboratories AG's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Buhlmann Laboratories AG have?
Buhlmann Laboratories AG has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does Buhlmann Laboratories AG file in?
Buhlmann Laboratories AG files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Buhlmann Laboratories AG's most well-known trademarks?
Buhlmann Laboratories AG's registered trademark portfolio includes well-known marks such as CAST. These are among 1 currently registered trademark in the portfolio.
What is Buhlmann Laboratories AG's trademark registration success rate?
Buhlmann Laboratories AG has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.